Norwegian Constraint-Induced (CI) Therapy Multisite Trial (NORCIMT)

October 9, 2013 updated by: University Hospital of North Norway

Intensive Training of Arm and Hand Function in People With Stroke - A Randomized Controlled Multisite Trial.

The purpose of this study is to determine whether modified CI therapy treatment is suitable and effective in the early rehabilitation after stroke, and to compare early CI intervention with a later CI intervention group.

Study Overview

Status

Terminated

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

47

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Levanger, Norway, N-7600
        • Levanger Hospital
      • Oslo, Norway, N-0514
        • Oslo University Hospital, Aker
      • Stavern, Norway, 3294
        • Vestfold Klinikk Fysikalske medisin og rehabilitering, Kysthospital
    • Sør-Trøndelag
      • Trondheim, Sør-Trøndelag, Norway, N-7006
        • Trondheim University Hospital
    • Troms
      • Tromsø, Troms, Norway, N-9038
        • University Hospital of North Norway

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Stroke at more than 5 and less than 26 days ago.(Either first stroke or second stroke without detectable arm weakness after the first stroke).
  • Modified ranking scale 0-2 before admission
  • Persistent unilateral arm or hand paresis (Scandinavian Strokes scale (SSS) arm motor function 2-5 or SSS hand motor function 2-4)
  • Able to lift two fingers with the forearm pronated on the table or able to extend the wrist at least 10 degrees from fully flexed position.
  • Able to follow a two step command.
  • Mini Mental State examination score of more than 20 (or more than 16 in combination with expressive aphasia)

Exclusion Criteria:

  • Modified Rankin Scale > 4
  • Unable to give informed consent
  • Large hemispatial neglect (more than two cm on the Line Bisection Test)
  • Not expected to survive one year due to other illnesses (eg cardiac, malignancy)
  • Injury or condition in the affected upper extremity that limited use prior to the stroke.
  • Other neurological condition affecting motor function

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early intervention
Modified CI therapy starting between 7 and 28 days post stroke.
10 treatment days 3 hours a day: Shaping exercises 2 hours. Task practice 0,5 hours. Behavioral therapy (Transfer package) 0,5 hour. Encouragement to wear a restraining mitt on the least affected arm for all safe activities.
Other Names:
  • CIMT
  • Constraint induced movement therapy
  • Modified constraint induced movement therapy
  • mCIMT
  • Forced use therapy
Active Comparator: Delayed intervention
Modified CI Therapy starting 6 months post stroke
10 treatment days 3 hours a day: Shaping exercises 2 hours. Task practice 0,5 hours. Behavioral therapy (Transfer package) 0,5 hour. Encouragement to wear a restraining mitt on the least affected arm for all safe activities.
Other Names:
  • CIMT
  • Constraint induced movement therapy
  • Modified constraint induced movement therapy
  • mCIMT
  • Forced use therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Wolf Motor function test
Time Frame: 6 months post inclusion
6 months post inclusion

Secondary Outcome Measures

Outcome Measure
Time Frame
Arm use accelerometry
Time Frame: 6 months
6 months
Fugl Meyer Motor Assessment
Time Frame: 6 months
6 months
Nine hole peg test
Time Frame: 6 months
6 months
Wolf Motor Function Test
Time Frame: 12 months
12 months
Arm use accelerometry
Time Frame: 12 months
12 months
Fugl Meyer Motor Assessment
Time Frame: 12 months
12 months
Nine Hole Peg Test
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Gyrd Thrane, Cand. San., University Hospital of North Norway
  • Study Chair: Audny GM Anke, MD, PhD, University Hospital of North Norway
  • Principal Investigator: Bent Indredavik, MD, PhD, Trondheim University Hospital
  • Principal Investigator: Torunn Askim, PhD, Norwegian University of Technology and Science
  • Principal Investigator: Roland Stock, MSc, Trondheim University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2008

Primary Completion (Actual)

January 1, 2013

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

May 19, 2009

First Submitted That Met QC Criteria

May 20, 2009

First Posted (Estimate)

May 21, 2009

Study Record Updates

Last Update Posted (Estimate)

October 10, 2013

Last Update Submitted That Met QC Criteria

October 9, 2013

Last Verified

October 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebrovascular Accident

Clinical Trials on Modified CI therapy

3
Subscribe